Controlled-Porosity Osmotic Pump Tablets-An Overview


  • Andhra University, A. U. College of Pharmaceutical Sciences, Visakhapatnam, Andhra Pradesh, 530003, India
  • M.A.M. College of Pharmacy, Narasaraopet, Andhra Pradesh, 522601, India


Conventional drug delivery systems have little control over their drug release and almost no control over the effective concentration at the target site. This kind of dosing pattern may result in constantly changing, unpredictable plasma concentrations. Drugs can be delivered in a controlled pattern over a long period of time by the process of osmosis. Osmotic devices are the most promising strategy based systems for controlled drug delivery. They are the most reliable controlled drug delivery systems and could be employed as oral drug delivery systems. The present review is concerned with the study of drug release systems which are tablets coated with walls of controlled porosity. When these systems are exposed to water, low levels of water soluble additive is leached from polymeric material i.e. semipermeable membrane and drug releases in a controlled manner over an extended period of time. Drug delivery from this system is not influenced by the different physiological factors within the gut lumen and the release characteristics can be predicted easily from the known properties of the drug and the dosage form. In this paper, various types of osmotically controlled drug delivery systems and the basic components of controlled porosity osmotic pump tablets have been discussed briefly.


Osmotic Pump, Controlled - Porosity Osmotic Pump Tablet, Semipermeable Membrane, Osmogent, Leachable Pore Formers.

Subject Discipline

Pharmacy and Pharmacology

Full Text:


Aulton M. E. Pharmaceutics The Science of Dosage form Design. Churchill Livingstone Press Elsevier. Third edition, 2007; pp.461.

M. C. Gohel, Parikh .R.K, Shah. N.Y. Osmotic Drug Delivery: An Update. Pharma 2009; 7: 2.

Suresh Vyas P., Prabakaran D., Paramjit Singh, Parijat Kanaujia, Jaganathan K.S., Amith Rawat. Modified push-pull osmotic system for simultaneous delivery of Theophylline and Salbutamol: development and in vitro characterization. Int. J. Pharm. 2004; 284: 95-108.

Roger Rajewski A., et al. Applicability of (SBE)7m - -CD in controlled-porosity osmotic pump tablets (OPTs). Int. J. Pharm. 2004; 286: 81-88.

Roger Rajewski A., et al. Factors affecting membrane controlled drug release for an osmotic pump tablet utilizing (SBE)7m - -CD as both a solubilizer and osmotic agent. J. Control. Rel. 1999; 60: 311-319.

Giancarlo Santus, Richard Baker W. Osmotic drug Delivery: a review of the patent literature. J Control. Rel. 1995; 35: 1-21.

Kazuto Okimoto, Roger A. Rajewski, and Valentino J. Stella. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-cyclodextrin as both a solubilizing and an osmotic pump agent J. Control. Rel. 1999; 58: 29-38.

Hai Bang Lee, Longxiao Liu, Jeong Ku, Gilson Khang, Bong Lee, John M.Rhee. Nifedipine controlled delivery sandwiched osmotic tablet system. J. Control. Rel. 2000; 68: 145-156.

Shailesh Sharma. Osmotic controlled drug delivery. 2008; 6(3).

Toshiaki Nagakura, Ken Ishihara, Toshiyuki Furukawa, Kohji Masuda, Takao Tsuda. Auto-regulated Osmotic pump for insulin therapy by sensing glucose concentration without energy supply. Sensors and Actuators B. 1996; 34: 229-233.

Herbig S.M., Cardinal J.R., Korsmeyer K.L., Smith K.L. Asymmetric-membrane tablet coatings for osmotic drug delivery. J. Control. Rel. 1995; 35: 127-136.

Mahalaxmi.R, Phanidhar Sastri1, Ravikumar, Atin Kalra, Pritam Kanagale, Narkhede. Enhancement of Dissolution of Glipizide from Controlled Porosity Osmotic Pump Using a Wicking Agent and a Solubilizing Agent. Int. J. PharmTech Res. 2009; 1, (3): 705-711.

Pradeep Vavia R., Sapna Makhija N. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine 1. Cellulose acetate as semipermeable membrane. J. Control. Rel. 2003; 89; 5-18.

Ji-Eon Kim, Seung-Ryul Kim, Sun-Hee Lee, Chi-Ho Lee and Dae-Duk Kim. The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix. Int. J. Pharm. 2000; 201: 29-36.

Gaylen Zentner M., Gerald S. Rork and Kenneth J. Himmerstein. THE CONTROLLED POROSITY OSMOTIC PUMP. J. Control. Rel. 1985; 1: 269-282.

Rajan Verma K., Kivi Murali Krishna, Sanjay Garg. Formulation aspects in the development of Osmotically Controlled Oral Drug Delivery Systems (OCODDs). J. Control. Rel. 2002; 79: 7-27.

Gaylen Zentner M., Gregory McCelland A., Steven Sutton C. Controlled porosity solubility and resin-modulated osmotic drug delivery systems for release of Diltiazem hydrochloride. J. Control. Rel. 1991; 16: 237-244.

Sanjay Garg, Rajan Verma k., Aditya Kaushal M. Development and evaluation of extended release formulations of Isosorbide mononitrate based on osmotic technology. Int. J. Pharm. 2003; 263: 924.

Andrew Tasker R., Tracy Doucette A., Catherine Ryan L. Use of osmotic minipumps for sustained drug delivery in rat pups: effects on physical and Neurobehavioral Development. Physiology & Behaviour. 2000; 71: 207212.

AK Philip, Kamla Patha. In situ formed phase transited drug delivery system of ketoprofen for achieving osmotic, controlled and level a in vitro in vivo correlation. Ind. J. pharm. Sci. 2008; 70, 6: 745-753.

Longxiao Liu, Xiangning Xu. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. Int. J. Pham. 2008; 352, (1-2):225-230.

Hsiu-O Ho, Ying-Ku Lin. Investigations on the drug releasing mechanism from an Asymmetric membrane-coated capsule with an in situ formed delivery orifice. J. Control. Rel. 2003; 89: 57-69.

Ming-Thau Sheu, Chun-Yu Wang, HsiuO Ho, Ling-Hong Lin, Ying-Ku Lin. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int. J. Pharm. 2005; 297: 89-97.


  • There are currently no refbacks.